{"name":"Kaichun Wu","slug":"kaichun-wu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQY1I2eE5rWUs1WnQ2U3ZRdXVYaTNzSHlkX0J0SjhCLWp2eUJMUzFfempoTC1rMXFheG16a2g1X0V6SmE2UzdUTTVUNEpQSHdoNGRvellud2V0TV8wOTE3RUpzb1hOaTdlM3E2OF9aSVRzekF5WmU1UkV6aV84QUo4eVg0QTNfRW00XzcyMko3YjJ0VjhrbnY3S0NuWk9ON2JWNTRUQ09fWFJyUWk3UWpBNkRhT2NzTnl5UDhwRXZqR1ljYk02NjQ1bVhGdERqVDNoaV9fT3ZDX2c5WFpNc2lqWVliQWY0LXF2RldXYVN0TUVRaU1pT2lrcEx2cw?oc=5","date":"2024-12-13","type":"pipeline","source":"BioPharma APAC","summary":"Everest Medicines Announces First Prescription of VELSIPITY® for Ulcerative Colitis in Macau, Marking a Key Milestone in Asia - BioPharma APAC","headline":"Everest Medicines Announces First Prescription of VELSIPITY® for Ulcerative Colitis in Macau, Marking a Key Milestone in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5jRGRyS1FDdWtydUZwcHIwRjZpZHRiUzVNT2todkZWd0FfMXgzdnFwb0VZSkp5RHloaVdObld4LXdnQ1d0Ym00cTJmUUdwX1ZhXzBYN1VZNHp6Snd3OGNqTjItMndUc3dkZWoyTQ?oc=5","date":"2024-12-02","type":"pipeline","source":"팜뉴스","summary":"Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong - 팜뉴스","headline":"Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong - 팜뉴스","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}